Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OFIX 
Orthofix Medical Inc (OFIX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: OFIX (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $22.55
1 Year Target Price $22.55
| 2 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -57.05% | Avg. Invested days 26 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 586.10M USD | Price to earnings Ratio - | 1Y Target Price 22.55 |
Price to earnings Ratio - | 1Y Target Price 22.55 | ||
Volume (30-day avg) 5 | Beta 0.86 | 52 Weeks Range 10.24 - 20.73 | Updated Date 09/17/2025 |
52 Weeks Range 10.24 - 20.73 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.17 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -15.29% | Operating Margin (TTM) -8.25% |
Management Effectiveness
Return on Assets (TTM) -5.95% | Return on Equity (TTM) -24.64% |
Valuation
Trailing PE - | Forward PE 33 | Enterprise Value 725226892 | Price to Sales(TTM) 0.72 |
Enterprise Value 725226892 | Price to Sales(TTM) 0.72 | ||
Enterprise Value to Revenue 0.9 | Enterprise Value to EBITDA 196.91 | Shares Outstanding 39494300 | Shares Floating 39008486 |
Shares Outstanding 39494300 | Shares Floating 39008486 | ||
Percent Insiders 2.76 | Percent Institutions 91.95 |
Upturn AI SWOT
Orthofix Medical Inc
Company Overview
History and Background
Orthofix Medical Inc. was founded in 1980. Initially focused on external fixation, it has evolved through acquisitions and internal development to offer a broader portfolio of orthopedic and spine solutions. Key milestones include the merger with SeaSpine in 2023 and subsequent name change to Orthofix Medical Inc.
Core Business Areas
- Spine: Focuses on spinal hardware, biologics, and enabling technologies to address various spinal pathologies. Includes products for spinal fusion, motion preservation, and non-surgical pain management.
- Orthopedics: Offers products for fracture repair, limb reconstruction, and bone growth stimulation. Includes external fixation devices, bone grafts, and regenerative solutions.
- Biologics: Includes bone grafts and cellular therapies designed to promote bone healing and tissue regeneration.
Leadership and Structure
The leadership team includes executives such as the CEO, CFO, and heads of various business units. The organizational structure is based on functional areas (e.g., sales, marketing, R&D, manufacturing) and business segments (Spine, Orthopedics, Biologics).
Top Products and Market Share
Key Offerings
- M6-C Artificial Cervical Disc: An artificial cervical disc for treating cervical disc disease. Competitors include Medtronic (MDT) and Johnson & Johnson (JNJ). Market share data is not publicly available for individual products.
- FORZA Expandable Interbody System: An expandable interbody device used in spinal fusion procedures. Competitors include Stryker (SYK) and Nuvasive (NUVA). Market share data is not publicly available for individual products.
- Physio-Stim: A bone growth stimulator used to accelerate fracture healing. Competitors include Zimmer Biomet (ZBH) and DJO Global. Market share data is not publicly available for individual products.
Market Dynamics
Industry Overview
The orthopedic and spine market is driven by an aging population, increasing prevalence of musculoskeletal disorders, and advancements in medical technology. It's a competitive landscape with continuous innovation and consolidation.
Positioning
Orthofix Medical Inc. positions itself as a provider of innovative solutions for orthopedic and spine care, emphasizing its comprehensive portfolio and focus on patient outcomes.
Total Addressable Market (TAM)
The global orthopedic and spine market is estimated to be in the tens of billions of dollars. Orthofix Medical Inc. aims to capture a significant portion of this market through product innovation, strategic acquisitions, and geographic expansion. TAM estimated at $50 billion in 2024. Orthofix is well positioned with its broad product portfolio and ongoing innovation.
Upturn SWOT Analysis
Strengths
- Broad product portfolio
- Established brand reputation
- Strong distribution network
- Focus on innovation
- Experienced management team
Weaknesses
- High debt levels
- Integration challenges from acquisitions
- Dependence on key products
- Limited market share in certain segments
- Product recall risk
Opportunities
- Expanding into emerging markets
- Developing new products and technologies
- Acquiring complementary businesses
- Increasing adoption of minimally invasive procedures
- Capitalizing on the aging population
Threats
- Increasing competition
- Pricing pressures
- Regulatory changes
- Economic downturns
- Product liability claims
Competitors and Market Share
Key Competitors
- MDT
- JNJ
- SYK
- ZBH
- BSX
- GLOB
Competitive Landscape
Orthofix Medical Inc. competes with larger players in the orthopedic and spine market. Its advantages include a focused product portfolio and strong distribution network. Disadvantages include limited scale and financial resources compared to larger competitors.
Major Acquisitions
SeaSpine
- Year: 2023
- Acquisition Price (USD millions): N/A
- Strategic Rationale: The merger with SeaSpine created a leading global spine and orthopedics company with a comprehensive portfolio and expanded reach.
Growth Trajectory and Initiatives
Historical Growth: Orthofix Medical Inc.'s historical growth has been driven by organic product development, strategic acquisitions and mergers, and geographic expansion.
Future Projections: Analyst projections vary. Check recent analyst reports for updated projections.
Recent Initiatives: Recent initiatives include the merger with SeaSpine, product launches, and expansion into new markets.
Summary
Orthofix Medical Inc. is a mid-sized player in the orthopedic and spine market with a broad product portfolio and ongoing innovation. The merger with SeaSpine has strengthened its position, but the company faces challenges related to competition and debt. Its growth will depend on successful product launches and market expansion, while navigating regulatory and economic headwinds. The company must also work to successfully integrate SeaSpine.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC filings
- Industry reports
- Analyst reports
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Investment decisions should be made based on independent research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Orthofix Medical Inc
Exchange NASDAQ | Headquaters Lewisville, TX, United States | ||
IPO Launch date 1992-04-24 | President, CEO & Director Mr. Massimo Calafiore | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1616 | Website https://orthofix.com |
Full time employees 1616 | Website https://orthofix.com | ||
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.